Filing Details
- Accession Number:
- 0001209191-21-039204
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-09 16:53:58
- Reporting Period:
- 2021-06-07
- Accepted Time:
- 2021-06-09 16:53:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649094 | Vaxcyte Inc. | PCVX | Biological Products, (No Disgnostic Substances) (2836) | 464233385 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1813800 | Jeff Fairman | C/O Vaxcyte, Inc. 353 Hatch Drive Foster City CA 94404 | Vp, Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-07 | 7,259 | $0.04 | 12,403 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-06-07 | 2,241 | $1.79 | 14,644 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-06-07 | 9,500 | $22.50 | 5,144 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-06-07 | 7,259 | $0.00 | 7,259 | $0.04 |
Common Stock | Stock Option (right to buy) | Disposition | 2021-06-07 | 2,241 | $0.00 | 2,241 | $1.79 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-04-23 | No | 4 | M | Direct | |
86,595 | 2027-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 341,227 | Indirect | By Fairman Family Trust |
Common Stock | 50,000 | Indirect | By AF 2020 Irrevocable Trust |
Footnotes
- Includes 943 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The shares subject to the option are fully vested and exercisable.
- 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48th of the shares vest monthly thereafter.